{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:48:44Z","timestamp":1790668124506,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Programme Hospitalier de Recherche Clinique National, PHRC 2016"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3247-1","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T14:08:05Z","timestamp":1551794885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)"],"prefix":"10.1186","volume":"20","author":[{"name":"for the STOP-OR-NOT study investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Legrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Futier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Deniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Plaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Coriat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Gayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"3247_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(12)61148-9","volume":"380","author":"RM Pearse","year":"2012","unstructured":"Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012;380:1059\u201365.","journal-title":"Lancet"},{"key":"3247_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1301082","volume":"369","author":"E Futier","year":"2013","unstructured":"Futier E, Constantin J-M, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369:428\u201337.","journal-title":"N Engl J Med"},{"key":"3247_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00000542-199408000-00006","volume":"81","author":"P Coriat","year":"1994","unstructured":"Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994;81:299\u2013307.","journal-title":"Anesthesiology"},{"key":"3247_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1213\/01.ANE.0000146521.68059.A1","volume":"100","author":"T Comfere","year":"2005","unstructured":"Comfere T, Sprung J, Kumar MM, Draper M, Wilson DP, Williams BA, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005;100:636\u201344.","journal-title":"Anesth Analg"},{"key":"3247_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1213\/ANE.0000000000000758","volume":"120","author":"B Mets","year":"2015","unstructured":"Mets B. To stop or not? Anesth Analg. 2015;120:1413\u20139.","journal-title":"Anesth Analg"},{"key":"3247_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1213\/ANE.0000000000000076","volume":"118","author":"RS Twersky","year":"2014","unstructured":"Twersky RS, Goel V, Narayan P, Weedon J. The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients. Anesth Analg. 2014;118:938\u201344.","journal-title":"Anesth Analg"},{"key":"3247_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00000539-200101000-00006","volume":"92","author":"M Bertrand","year":"2001","unstructured":"Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg. 2001;92:26\u201330.","journal-title":"Anesth Analg"},{"key":"3247_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","volume":"126","author":"PS Roshanov","year":"2017","unstructured":"Roshanov PS, Rochwerg B, Patel A, Salehian O, Duceppe E, Belley-C\u00f4t\u00e9 EP, et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort. Anesthesiology. 2017;126:16\u201327.","journal-title":"Anesthesiology"},{"key":"3247_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/jhm.323","volume":"3","author":"DJ Rosenman","year":"2008","unstructured":"Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, LaBella M, Montori VM. Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med. 2008;3:319\u201325.","journal-title":"J Hosp Med"},{"key":"3247_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/bja\/72.6.633","volume":"72","author":"M B\u00f6ttcher","year":"1994","unstructured":"B\u00f6ttcher M, Behrens JK, M\u00f8ller EA, Christensen JH, Andreasen F. ACE inhibitor premedication attenuates sympathetic responses during surgery. Br J Anaesth. 1994;72:633\u20137.","journal-title":"Br J Anaesth"},{"key":"3247_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891\u2013975.","journal-title":"Eur J Heart Fail"},{"key":"3247_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/ALN.0000000000000739","volume":"123","author":"SM Lee","year":"2015","unstructured":"Lee SM, Takemoto S, Wallace AW. Association between withholding angiotensin receptor blockers in the early postoperative period and 30-day mortality: a cohort study of the Veterans Affairs Healthcare System. Anesthesiology. 2015;123:288\u2013306.","journal-title":"Anesthesiology"},{"key":"3247_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2369-15-53","volume":"15","author":"M Shah","year":"2014","unstructured":"Shah M, Jain AK, Brunelli SM, Coca SG, Devereaux PJ, James MT, et al. Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol. 2014;15:53.","journal-title":"BMC Nephrol"},{"key":"3247_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/jama.2017.14172","volume":"318","author":"E Futier","year":"2017","unstructured":"Futier E, Lefrant J-Y, Guinot P-G, Godet T, Lorne E, Cuvillon P, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318:1346\u201357.","journal-title":"JAMA"},{"key":"3247_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jamcollsurg.2007.07.026","volume":"205","author":"AQ Ereso","year":"2007","unstructured":"Ereso AQ, Ramirez RM, Sadjadi J, Cripps MW, Cureton EL, Curran B, et al. Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak. J Am Coll Surg. 2007;205:527\u201333.","journal-title":"J Am Coll Surg"},{"key":"3247_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.thromres.2015.12.008","volume":"138","author":"A Gromotowicz-Poplawska","year":"2016","unstructured":"Gromotowicz-Poplawska A, Stankiewicz A, Kramkowski K, Gradzka A, Wojewodzka-Zelezniakowicz M, Dzieciol J, et al. The acute prothrombotic effect of aldosterone in rats is partially mediated via angiotensin II receptor type 1. Thromb Res. 2016;138:114\u201320.","journal-title":"Thromb Res"},{"key":"3247_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/eci.12401","volume":"45","author":"AR Silva da","year":"2015","unstructured":"da Silva AR, Fraga-Silva RA, Stergiopulos N, Montecucco F, Mach F. Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis. Eur J Clin Investig. 2015;45:274\u201387.","journal-title":"Eur J Clin Investig"},{"key":"3247_CR18","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"key":"3247_CR19","doi-asserted-by":"publisher","first-page":"75S","DOI":"10.1016\/0895-7061(95)00194-8","volume":"8","author":"F Zannad","year":"1995","unstructured":"Zannad F. Duration of action of angiotensin converting enzyme inhibitors. Am J Hypertens. 1995;8:75S\u201381S.","journal-title":"Am J Hypertens"},{"key":"3247_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jamasurg.2014.1819","volume":"150","author":"ML Schwarze","year":"2015","unstructured":"Schwarze ML, Barnato AE, Rathouz PJ, Zhao Q, Neuman HB, Winslow ER, et al. Development of a list of high-risk operations for patients 65 years and older. JAMA Surg. 2015;150:325\u201331.","journal-title":"JAMA Surg"},{"key":"3247_CR21","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1056\/NEJMoa1801601","volume":"378","author":"PS Myles","year":"2018","unstructured":"Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018;378:2263\u201374.","journal-title":"N Engl J Med"},{"key":"3247_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ahj.2010.06.013","volume":"160","author":"P Xiao","year":"2010","unstructured":"Xiao P, Ling Z, Woo K, Du H, Su L, Liu Z, et al. Renin-angiotensin system-related gene polymorphisms are associated with risk of atrial fibrillation. Am Heart J. 2010;160:496\u2013505.","journal-title":"Am Heart J"},{"key":"3247_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease: Improving Global Outcome (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcome (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1\u2013138.","journal-title":"Kidney Int Suppl"},{"key":"3247_CR24","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","volume":"35","author":"SD Kristensen","year":"2014","unstructured":"Kristensen SD, Knuuti J, Saraste A, Anker S, B\u00f8tker HE, Hert SD, et al. 2014 ESC\/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35:2383\u2013431.","journal-title":"Eur Heart J"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3247-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3247-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3247-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:21:32Z","timestamp":1583281292000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3247-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3247"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3247-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,5]]},"assertion":[{"value":"18 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correspondence should be addressed to Matthieu Legrand.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Included in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ML reports consulting fees from Novartis, lecture fees from Baxter and Freseniu, Research support from Shingotec. EF received consulting fees from Edwards Lifesciences, consulting fees from Drager, consulting fees from General Electric Healthcare, lecture fees from Fresenius Kabi, and lecture fees from Baxter. MLeone declares COIs with Amomed (consulting, lecture), Aguettant (consulting), MSD (consulting, lecture), Pfizer (lecture), Aspen (lecture), Orion (lecture), Octapharma (lecture). PR is a co-founder of CardioRenal and declares personal fees (consulting) from Novartis, NovoNordisk, Relypsa, AstraZeneca, Gr\u00fcnenthal, Idorsia, Stealth Peptides, Fresenius, Vifor Fresenius Medical Care Renal Pharma, Vifor, and Clinical Trials Mobile Application; and lecture fees from Bayer and CVRx. AM reports personal fees from Novartis, Orion, Roche, Servier, Cardiorentis, Adrenomed, ZSPharma, Abbott, Neuro Tronik, Sphingotec, research grants from Critical diagnostics, MyCartis and Adrenomed; BD, EV, PC, and BP declare no conflict of interest. EG declares consultant fees from Magnisense and Adrenomed and research fees from Retia Medical, Deltex Medical, and Sphingotec.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"160"}}